Dihydroartemisinin inhibits metastatic potential and cancer stemness by modulating the miR-200b–BMI-1/VEGF-A axis in ovarian cancer
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that dihydroartemisinin may inhibit the spread and stemness of ovarian cancer cells by affecting a specific molecular pathway. The study of this compound is part of a broader exploration of natural products and repurposed drugs as potential cancer therapies. Other research areas, including the role of the tumor microenvironment and ferroptosis in cancer, may also be relevant to understanding and treating various types of cancer.
Full coverage
12345678